光韻達(300227.SZ):擬以857.28萬元對協同創新高科技增資
格隆匯6月22日丨光韻達(300227.SZ)公佈,為了整合公司激光增材製造(3D打印)業務,專注於3D打印業務在航空航天領域的應用,參與和推進3D打印技術在其他行業領域如醫療行業、碳纖維材料等的應用,進一步提升公司的綜合競爭力和盈利能力,公司擬以自有資金出資人民幣857.28萬元對深圳協同創新高科技發展有限公司(“協同創新高科技”或“標的公司”)增資,此次投資完成後,公司將持有協同創新高科技35.72%的股權。
此次投資是公司通過外部參股合作的方式,參與和推進增材製造技術在其他創新領域的產政學研合作,有利於公司在3D打印領域參與到更廣泛的行業和領域,吸引更全面的人才和技術。同時,公司在內部業務架構上更加聚焦3D打印在航空航天與軍工領域的技術與應用,進一步提升公司綜合競爭力和盈利能力,符合公司的發展戰略。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.